UB Paderborn / Katalog / Suche / in CDI

qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States

Antimicrobial Agents and Chemotherapy, 2006-08, Vol.50 (8), p.2872-2874

2006

Volltextzugriff (PDF)

In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1918-1923

2016

Volltextzugriff (PDF)

In Vitro Activity of CEM-102 (Fusidic Acid) against Prevalent Clones and Resistant Phenotypes of Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4535-4536

2013

Volltextzugriff (PDF)

Broader Distribution of Plasmid-Mediated Quinolone Resistance in the United States

Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.3001-3003

2005

Volltextzugriff (PDF)

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998

Journal of antimicrobial chemotherapy, 2000-04, Vol.45 (4), p.457-466

2000

Volltextzugriff (PDF)

Relationships between Enterococcal Virulence and Antimicrobial Resistance

Clinical Microbiology Reviews, 2000-10, Vol.13 (4), p.513-522

2000

Volltextzugriff (PDF)

Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study

Antimicrobial Agents and Chemotherapy, 1999-11, Vol.43 (11), p.2612-2623

1999

Volltextzugriff (PDF)

Antimicrobial Resistance Among Uropathogens that Cause Community-Acquired Urinary Tract Infections in Women: A Nationwide Analysis

Clinical infectious diseases, 2001-07, Vol.33 (1), p.89-94

2001

Volltextzugriff (PDF)

Multidrug-resistant urinary tract isolates of Escherichia coli : Prevalence and patient demographics in the United States in 2000

Antimicrobial agents and chemotherapy, 2001-05, Vol.45 (5), p.1402-1406

2001

Volltextzugriff (PDF)

VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405

Antimicrobial Agents and Chemotherapy, 1999-09, Vol.43 (9), p.2161-2164

1999

Volltextzugriff (PDF)

Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database—USA

Clinical infectious diseases, 1999-08, Vol.29 (2), p.259-263

1999

Volltextzugriff (PDF)

Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3459-3464

2016

Volltextzugriff (PDF)

Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients

European journal of clinical microbiology & infectious diseases, 2004-06, Vol.23 (6), p.445-455

2004

Volltextzugriff (PDF)

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998

Journal of antimicrobial chemotherapy, 1999-12, Vol.44 (6), p.749-759

1999

Volltextzugriff (PDF)

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Clinical microbiology and infection, 2003-07, Vol.9 (7), p.590-599

2003

Volltextzugriff (PDF)

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season

Antimicrobial agents and chemotherapy, 2000-02, Vol.44 (2), p.462-466

2000

Volltextzugriff (PDF)

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

Antimicrobial Agents and Chemotherapy, 2001-04, Vol.45 (4), p.1037-1042

2001

Volltextzugriff (PDF)

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

Clinical microbiology and infection, 2002-04, Vol.8 (4), p.214-221

2002

Volltextzugriff (PDF)

Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2521-2524

2000

Volltextzugriff (PDF)

Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011–2013

Journal of global antimicrobial resistance., 2015-09, Vol.3 (3), p.190-197

2015

Volltextzugriff (PDF)

In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China

European journal of clinical microbiology & infectious diseases, 2016-12, Vol.35 (12), p.1933-1939

2016

Volltextzugriff (PDF)

Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003–2004)

International journal of antimicrobial agents, 2006-12, Vol.28 (6), p.525-531

2006

Volltextzugriff (PDF)

Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1295-1299

2004

Volltextzugriff (PDF)

Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.119-124

2002

Volltextzugriff (PDF)

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1681-1688

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States

In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

In Vitro Activity of CEM-102 (Fusidic Acid) against Prevalent Clones and Resistant Phenotypes of Staphylococcus aureus

Broader Distribution of Plasmid-Mediated Quinolone Resistance in the United States

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998

Relationships between Enterococcal Virulence and Antimicrobial Resistance

Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study

Antimicrobial Resistance Among Uropathogens that Cause Community-Acquired Urinary Tract Infections in Women: A Nationwide Analysis

Multidrug-resistant urinary tract isolates of Escherichia coli : Prevalence and patient demographics in the United States in 2000

VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405

Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database—USA

Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study

Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011–2013

In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China

Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003–2004)

Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States

Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

Suchergebnisse filtern